BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9005146)

  • 21. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma tetranectin and colorectal cancer.
    Høgdall CK; Christiansen M; Nørgaard-Pedersen B; Bentzen SM; Kronborg O; Clemmensen I
    Eur J Cancer; 1995 Jun; 31A(6):888-94. PubMed ID: 7646916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome.
    Nakafusa Y; Tanaka T; Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Dis Colon Rectum; 2004 Dec; 47(12):2055-63. PubMed ID: 15657654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
    Kos J; Nielsen HJ; Krasovec M; Christensen IJ; Cimerman N; Stephens RW; Brünner N
    Clin Cancer Res; 1998 Jun; 4(6):1511-6. PubMed ID: 9626470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors for survival after curative resection of Dukes' B colonic cancer.
    Saha AK; Smith KJ; Sue-Ling H; Sagar PM; Burke D; Finan PJ
    Colorectal Dis; 2011 Dec; 13(12):1390-4. PubMed ID: 21073647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.
    Inoue M; Ohta M; Iuchi K; Matsumura A; Ideguchi K; Yasumitsu T; Nakagawa K; Fukuhara K; Maeda H; Takeda S; Minami M; Ohno Y; Matsuda H;
    Ann Thorac Surg; 2004 Jul; 78(1):238-44. PubMed ID: 15223436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages].
    Cai SR; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):483-5. PubMed ID: 16188146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis?
    Bentzen SM; Balslev I; Pedersen M; Teglbjaerg PS; Hanberg-Soerensen F; Bone J; Jacobsen NO; Overgaard J; Sell A; Bertelsen K
    Br J Cancer; 1988 Aug; 58(2):195-201. PubMed ID: 3166910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal carcinoma in patients aged 75 years and more: factors influencing short and long-term operative mortality.
    Fabre JM; Rouanet P; Ele N; Fagot H; Guillon F; Deixonne B; Balmes M; Domergue J; Baumel H
    Int Surg; 1993; 78(3):200-3. PubMed ID: 8276540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.
    Kune GA; Kune S; Field B; White R; Brough W; Schellenberger R; Watson LF
    Dis Colon Rectum; 1990 Nov; 33(11):938-46. PubMed ID: 2226081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors for survival and disease-free survival in hepatic metastases from colorectal cancer treated by resection.
    Doci R; Bignami P; Montalto F; Gennari L
    Tumori; 1995; 81(3 Suppl):143-6. PubMed ID: 7571046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognosis of surgically treated colorectal neoplasms. Contribution of multivariate analysis].
    Huguier M; Rey C; Chastang C; Houry S; Lacaine F
    Gastroenterol Clin Biol; 1989 May; 13(5):463-8. PubMed ID: 2753282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of perioperative blood transfusion with colorectal cancer recurrence.
    Tartter PI
    Ann Surg; 1992 Dec; 216(6):633-8. PubMed ID: 1466616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival from colorectal cancer in Victoria: 10-year follow up of the 1987 management survey.
    McLeish JA; Thursfield VJ; Giles GG
    ANZ J Surg; 2002 May; 72(5):352-6. PubMed ID: 12028094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Lundin J; Järvinen H; Roberts P
    Eur J Cancer; 1996 Jun; 32A(7):1156-61. PubMed ID: 8758246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of colorectal cancer patients with elevated endothelin-1 concentrations.
    Elahi MM; Everson NW
    Asian J Surg; 2004 Jan; 27(1):4-9. PubMed ID: 14717137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of immunohistochemistry for collagen IV expression in colorectal carcinomas.
    Offerhaus GJ; Giardiello FM; Bruijn JA; Stijnen T; Molyvas EN; Fleuren GJ
    Cancer; 1991 Jan; 67(1):99-105. PubMed ID: 1985727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving patient survival with the colorectal cancer multi-disciplinary team.
    MacDermid E; Hooton G; MacDonald M; McKay G; Grose D; Mohammed N; Porteous C
    Colorectal Dis; 2009 Mar; 11(3):291-5. PubMed ID: 18477019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer.
    Bisgaard ML; Jäger AC; Dalgaard P; Søndergaard JO; Rehfeld JF; Nielsen FC
    Scand J Gastroenterol; 2001 Apr; 36(4):405-9. PubMed ID: 11336166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.